Cassava Sciences Inc (SAVA) concluded trading on Thursday at a closing price of $32.18, with 4.63 million shares of worth about $148.86 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 47.61% during that period and on November 21, 2024 the price saw a gain of about 23.53%. Currently the company’s common shares owned by public are about 42.24M shares, out of which, 41.77M shares are available for trading.
Stock saw a price change of 23.11% in past 5 days and over the past one month there was a price change of 14.97%. Year-to-date (YTD), SAVA shares are showing a performance of 42.96% which increased to 44.24% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $8.79 but also hit the highest price of $42.20 during that period. The average intraday trading volume for Cassava Sciences Inc shares is 1.63 million. The stock is currently trading 20.91% above its 20-day simple moving average (SMA20), while that difference is up 16.64% for SMA50 and it goes to 40.20% higher than SMA200.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Cassava Sciences Inc (NASDAQ: SAVA) currently have 42.24M outstanding shares and institutions hold larger chunk of about 29.65% of that.
The stock has a current market capitalization of $1.55B and its 3Y-monthly beta is at -0.60. It has posted earnings per share of -$1.37 in the same period. It has Quick Ratio of 3.55 while making debt-to-equity ratio of 0.00. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for SAVA, volatility over the week remained 14.17% while standing at 8.22% over the month.
Stock’s fiscal year EPS is expected to rise by 64.22% while it is estimated to increase by 160.24% in next year.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by H.C. Wainwright on October 08, 2024 offering a Buy rating for the stock and assigned a target price of $116 to it. On November 16, 2022, B. Riley Securities Downgrade their recommendations, while on July 15, 2021, Cantor Fitzgerald Downgrade their ratings for the stock with a price target of $100. Stock get a Buy rating from Maxim Group on July 07, 2021.
